Collplant Biotechnologies Earnings Estimate

CLGN Stock  USD 3.14  0.31  10.95%   
By analyzing Collplant Biotechnologies' earnings estimates, investors can diagnose different trends across Collplant Biotechnologies' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Collplant Biotechnologies is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Collplant Biotechnologies is projected to generate -0.07875 in earnings per share on the 31st of December 2025. Collplant Biotechnologies earnings estimates show analyst consensus about projected Collplant Biotechnologies EPS (Earning Per Share). It derives the highest and the lowest estimates based on Collplant Biotechnologies' historical volatility. Many public companies, such as Collplant Biotechnologies, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Collplant Biotechnologies' earnings estimates, investors can diagnose different trends across Collplant Biotechnologies' analyst sentiment over time as well as compare current estimates against different timeframes. As of the 27th of September 2025, Gross Profit is likely to grow to about (1.1 M). In addition to that, Pretax Profit Margin is likely to drop to -33.86Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collplant Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.

Collplant Biotechnologies Earnings per Share Projection vs Actual

About Collplant Biotechnologies Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Collplant Biotechnologies earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Collplant Biotechnologies estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Collplant Biotechnologies fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-113.3 M-107.7 M
Earnings Yield(0.40)(0.42)
Price Earnings Ratio(2.48)(2.36)
Price Earnings To Growth Ratio(0.02)(0.02)

Pair Trading with Collplant Biotechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Collplant Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collplant Biotechnologies will appreciate offsetting losses from the drop in the long position's value.

Moving together with Collplant Stock

  0.68EQ EquilliumPairCorr
  0.72DMAC DiaMedica TherapeuticsPairCorr
  0.74VALN Valneva SE ADRPairCorr

Moving against Collplant Stock

  0.71VCEL Vericel Corp OrdPairCorr
  0.51DRMA Dermata Therapeutics Upward RallyPairCorr
The ability to find closely correlated positions to Collplant Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Collplant Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Collplant Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Collplant Biotechnologies to buy it.
The correlation of Collplant Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Collplant Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Collplant Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Collplant Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Collplant Biotechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Collplant Biotechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Collplant Biotechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Collplant Biotechnologies Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collplant Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.25)
Revenue Per Share
0.208
Quarterly Revenue Growth
(0.28)
Return On Assets
(0.38)
Return On Equity
(0.78)
The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.